TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/18 20:35 | 3/16/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gardner Phyllis | CA | D | M.d | 14 | 2.55 | 0 | 5 | 3 | D | ||||||||||||||||
3/16/18 20:35 | 3/16/18 | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gardner Phyllis | CA | D | S.d | -168 | 31.51 | 0 | -5 | -64 | 3 | D | |||||||||||||||
8/21/17 18:07 | 8/21/17 | CORI | Corium International, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gardner Phyllis | CA | D | M.d | 70 | 2.12 | 0 | 33 | 999% | 34 | D | |||||||||||||||
3/30/15 17:36 | 3/27/15 | CORI | Corium International, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gardner Phyllis | CA | D | M.d | 0 | 0.2020 | 0 | 1 | New | 1 | D | 9 | 16 | 0 | 3 | 3 | -2 | -6 | 2 | 12 | 96 | 26 | -39 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |